摘要The evolving treatment landscape of hepatocellular carcinoma(HCC)includes curative treatments such as ablation,resection,and transplantation,along with palliative interventions such as locoregional and systemic therapies.Evaluating the response to therapy is critical to planning the next intervention or follow-up needed,as well as for comparing the outcomes across the treatment options.Response to therapy can be measured using serum markers,through pathology,using imaging surrogates,and clinical response.This review provides a brief overview of these measures of treatment response and their relevance to HCC management.
更多相关知识
- 浏览2
- 被引0
- 下载0

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文